Search research articles
Contact Us
Filters
Showing results (91-100 of 179) with videos related to
Page
of 18
Sort By:
American Journal of Hematology
|
October 29, 2020
Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study
Daniel A Pollyea, Keith Pratz, Anthony Letai, et al.
American Journal of Hematology
|
February 22, 2021
A Phase I dose-escalation study of DCLL9718S, an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1) in patients with acute myeloid leukemia
Naval Daver, Amandeep Salhotra, Joseph M Brandwein, et al.
The Journal of Clinical Investigation
|
March 2, 2016
MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia
Simone S Riedel, Jessica N Haladyna, Matthew Bezzant, et al.
Journal of Hematology & Oncology
|
July 16, 2020
Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy
Jorge E Cortes, Florian H Heidel, Walter Fiedler, et al.
Cancer Cell
|
February 13, 2019
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
Courtney L Jones, Brett M Stevens, Angelo D'Alessandro, et al.
Cancer Cell
|
November 14, 2018
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
Courtney L Jones, Brett M Stevens, Angelo D'Alessandro, et al.
Blood Advances
|
October 5, 2021
Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia
Evan M Cherry, Diana Abbott, Maria Amaya, et al.
Cell Reports
|
March 30, 2017
Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia
Alyssa Carey, David K Edwards, Christopher A Eide, et al.
Transplantation and Cellular Therapy
|
August 18, 2024
Outcomes of Haplo-Cord Versus Dual Cord Transplants: A Single-Center Retrospective Analysis
Andrew Kent, Kellen B Gil, Michael K Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2018
Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS
Michael R Savona, Daniel A Pollyea, Wendy Stock, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 179) with videos related to
Sort By:
Page
of 18
American Journal of Hematology
|
October 29, 2020
Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study
Daniel A Pollyea, Keith Pratz, Anthony Letai, et al.
American Journal of Hematology
|
February 22, 2021
A Phase I dose-escalation study of DCLL9718S, an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1) in patients with acute myeloid leukemia
Naval Daver, Amandeep Salhotra, Joseph M Brandwein, et al.
The Journal of Clinical Investigation
|
March 2, 2016
MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia
Simone S Riedel, Jessica N Haladyna, Matthew Bezzant, et al.
Journal of Hematology & Oncology
|
July 16, 2020
Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy
Jorge E Cortes, Florian H Heidel, Walter Fiedler, et al.
Cancer Cell
|
February 13, 2019
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
Courtney L Jones, Brett M Stevens, Angelo D'Alessandro, et al.
Cancer Cell
|
November 14, 2018
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
Courtney L Jones, Brett M Stevens, Angelo D'Alessandro, et al.
Blood Advances
|
October 5, 2021
Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia
Evan M Cherry, Diana Abbott, Maria Amaya, et al.
Cell Reports
|
March 30, 2017
Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia
Alyssa Carey, David K Edwards, Christopher A Eide, et al.
Transplantation and Cellular Therapy
|
August 18, 2024
Outcomes of Haplo-Cord Versus Dual Cord Transplants: A Single-Center Retrospective Analysis
Andrew Kent, Kellen B Gil, Michael K Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2018
Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS
Michael R Savona, Daniel A Pollyea, Wendy Stock, et al.
Page
of 18